A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/08/2006	EP1719527A1 Antitumor agent
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1719509A1 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
11/08/2006	EP1719506A1 Gene expression controlling agent
11/08/2006	EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718737A1 Cancerous disease modifying antibodies
11/08/2006	EP1718736A1 Cancerous disease modifying antibodies
11/08/2006	EP1718667A2 Heterocyclic self-immolative linkers and conjugates
11/08/2006	EP1718651A2 7h-pyrrolopyrimidine derivatives
11/08/2006	EP1718645A1 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718631A2 Cytotoxin compound and method of isolation
11/08/2006	EP1718623A1 Compounds as inhibitors of cell proliferation and viral infections
11/08/2006	EP1718618A1 Pyrazoline derivatives useful for the treatment of cancer
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718614A1 Pyridinamide derivative as kinase inhibitors
11/08/2006	EP1718602A1 Therapeutic and carrier molecules
11/08/2006	EP1718367A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
11/08/2006	EP1718340A2 New effector conjugates, process for their production and their pharmaceutical use
11/08/2006	EP1718332A1 Method for inhibiting the transendothelial migration of cells such as leukocytes or tumor cells by a cd-81 binding subsance and uses thereof
11/08/2006	EP1718323A2 Binding peptidomimetics and uses of the same
11/08/2006	EP1718322A2 Antitumor agent
11/08/2006	EP1718310A2 Methods and compositions for treating tumors and metastatic disease
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1718283A2 Topical co-enzyme q10 formulations and methods of use
11/08/2006	EP1718280A2 Methods and compositions for treating cancer
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1429761B1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1278518B1 Synergistic combination for the treatment of colorectal cancer
11/08/2006	EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006	EP1242438B1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	CN1860229A Recombinant protein with cancer suppression action and its encoding gene and use
11/08/2006	CN1860129A Novel peptide ligands of leukocyte integrins
11/08/2006	CN1860121A Substituted imidazopyrimidines for the prevention and treatment of cancer
11/08/2006	CN1860106A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1860104A 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
11/08/2006	CN1859921A Method of processing ginseng for medicinal use and composition
11/08/2006	CN1858040A 5,8-disubstituted quinazoline and its preparing method and use
11/08/2006	CN1857737A Use of Ig CDR3 gene antisense in preparing tumor treating medicine
11/08/2006	CN1857736A Polyglycol modified antitumor compound and its preparing method
11/08/2006	CN1857728A Nanometer magnetic polylactic acid-phenyl arsine glycollate microballoon and its use
11/08/2006	CN1857720A Freeze dried human cell fibronection powder and its preparing method
11/08/2006	CN1857717A Anticancer peptide extract of blood clam and its preparing method
11/08/2006	CN1857697A Compound Chinese medicine Anxuekang and its preparing method
11/08/2006	CN1857684A Compound Chinese medicine preparation for removing toxic matter, dispersing blood clots and strengthing body's resistance and its preparaing process
11/08/2006	CN1857677A Oral medicine for treating hysteromyoma
11/08/2006	CN1857673A Curcumenol preparation
11/08/2006	CN1857660A Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer
11/08/2006	CN1857648A Compound Chinese medicine preparation for clearing away heat and toxic matter, softening dry feces, dissipating mass, nourishing Yin and benefiting Qi and its preparing process
11/08/2006	CN1857644A Medicine for treating tumor in upper digestive tract and its preparing method
11/08/2006	CN1857616A Chinese medicine for treating cirrhosis, liver ascites and early hepatoma
11/08/2006	CN1857596A Cancer treating medicine composition and its preparing method
11/08/2006	CN1857575A Compound Chinese medicine preparation for treating primary liver carcinoma caused by stagnation of liver-Qi and poisonous obstruction and its preparing process
11/08/2006	CN1857566A Compound dioecious balanophora herb capsule
11/08/2006	CN1857565A Anticancer compound Chinese medicine powder and its preparing method
11/08/2006	CN1857557A Preparing process of Chinese medicine for treating stomach cancer and esophagus carcinoma
11/08/2006	CN1857529A Neogarcinolic acid injection for treating tumor and its preparing method
11/08/2006	CN1857408A Scullcap stem and leaf injection powder and its preparing method
11/08/2006	CN1857351A Antitumor medicine composition and its preparing method
11/08/2006	CN1857334A Glossy ganoderma spore oil emulsion for intravenous injection and its preparing method
11/08/2006	CN1857332A Selenium-rich hedgehog fungus extract preparation for treating colitis, gastritis and stomach cancer and its preparing process
11/08/2006	CN1857322A Antitumor animal medicine and its preparing method
11/08/2006	CN1857300A Freeze dried ginseng polysaccharide powder for injection and its preparing process
11/08/2006	CN1857299A New use of mankshood polysaccharide in preventing and treating post-chemotherapy bone marrow arrest
11/08/2006	CN1857273A Ursolate microballoon preparation and its preparing process
11/08/2006	CN1857267A Suppository for auxiliary treatment of cervical carcinoma and its preparing method
11/08/2006	CN1857256A Coated norcantharidin tablet and its preparing method
11/08/2006	CN1857253A Anticancer injection of rabdosia diterpene compound or its derivative and its preparing method
11/08/2006	CN1857252A Rubescensin structural preparation composition
11/08/2006	CN1857250A Application of neotanshinone I-sodium sulfonate in preparing medicine
11/08/2006	CN1857247A Oxaliplatin emulsion for intravenous injection and its preparing method
11/08/2006	CN1857242A Externally applied tamoxifen citrate microemulsion preparation and its preparing process
11/08/2006	CN1857238A Emodin emulsion for injection and its preparing process
11/08/2006	CN1857232A Biodegradable nano magnetic capsule loading medicine and its preparing process
11/08/2006	CN1857231A Preparing process of biodegradable capsule loading medicine and nano magnetic particle
11/08/2006	CN1857224A Preparing process of nano c-FLIP antisense oligonucleotide particle
11/08/2006	CN1857223A Chitosan chloride coated nano hydroxycamptothecine liposome and its preparing process
11/08/2006	CN1857222A Submicron docetaxel emulsion for intravenous injection and its preparing process
11/08/2006	CN1857221A Slow released anticancer medicien containing both platinum compound and its synergist
11/08/2006	CN1857217A Slow released anticancer injection containing estrogen receptor antagonist
11/08/2006	CN1857216A Slow released injection containing satraplatin and its synergist
11/08/2006	CN1857215A Slow released injection containing antimetabolite
11/08/2006	CN1857214A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857213A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857212A Slow released anticancer injection containing antimetabolite and cellular poison medicine
11/08/2006	CN1857211A Slow released injection containing Nolatrexed and its synergist
11/08/2006	CN1857210A Slow released anticancer medicine with both antimetabolite and its synergist
11/08/2006	CN1857209A Slow released anticancer injection containing antimetabolite
11/08/2006	CN1857208A Slow released anticancer injection with both antimetabolite and its synergist
11/08/2006	CN1857207A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857206A Slow released anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857205A Slow released injection containing blood vessel inhibitor and its synergist
11/08/2006	CN1857204A Slow released anticancer medicine with both blood vessel inhibitor and its synergist
11/08/2006	CN1857203A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857202A Slow released anticancer injection with blood vessel inhibitor and cellular poison medicine

1 ... 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 ... 2211